A year ago, the FDA took the unusual step of inserting itself into the controversy over the KV Pharmaceutical drug known as Makena, which the agency had approved for premature births under the Orphan ...

AAO Issues Statement on Pharmaceutical Compounding Legislation The American Academy of Ophthalmology has released a statement warning Congress of the unintended results of the proposed Pharmaceutical ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

STATE. WE’LL TELL YOU WHY. GOOD EVENING. I’M SHELLY RIBANDO. AND I’M DOUG FERNANDEZ. IT IS A CASE THAT MADE NATIONAL HEADLINES AND THE TRIAL IS OFFICIALLY UNDERWAY NOW HERE IN ALBUQUERQUE. FIVE PEOPLE ...

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply. The FDA's move is bad news for ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--The following is a statement from New England Compounding Center: “New England Compounding Center (NECC) is working closely with the Massachusetts Board of Pharmacy ...

Patients have been buying compounded weight loss drugs at lower prices than brand-name medications amid shortages of tirzepatide and semaglutide. (Getty Images) Compounding pharmacies will have to ...

LOUISVILLE, Ky. (WDRB) -- A nationwide shortage of popular weight loss medications has patients searching for alternatives, and many are turning to compounded versions. However, not all options are ...

WASHINGTON, Oct. 1, 2019 /PRNewswire/ -- Sunday night's episode of John Oliver's Last Week Tonight on HBO included a segment on pharmacy compounding. The American Pharmacists Association makes the ...

Five years ago, methylprednisolone acetate and other drugs compounded by the New England Compounding Center (NECC; Framingham, Mass.) and administered to patients throughout the United States caused a ...